The world of pharmacology, infectious diseases, and immunizations is constantly evolving.
As new guidelines are released, modern evidence published, and critical information updated… are you confident you can keep up with it?
You can with our new-and-improved online course — The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Coronavirus Updates.
This self-paced video training gives you:
- Practice at the forefront of current infectious disease evidence
- Insights into WHY an agent should be prescribed in a clinical scenario
- The confidence to know WHEN it’s safe to use a cephalosporin in a patient with a history of penicillin reaction
- Tips to combat bacterial resistance — with an emphasis on new antimicrobials and advances in evidence-based treatment guidelines
- Skills to expertly interpret culture and sensitivity results
- Up to 13.75 total contact hours – INCLUDING 8.6 pharmacology CE hours
- …And so much more!
Gain the most up-to-date knowledge you will want to share with your colleagues!
Get started today and become the pharmacology expert on your unit by your very next shift!
The Latest Pharmacology of Infectious Diseases & Immunizations:
Now with Critical Corona Virus Updates
Valued at $499.97 — Yours today for only $149.99!
Click here for CE credit details
See what your peers are saying about this care-elevating course:
Now with Critical Corona Virus Updates
$499.97 Value
Just $149.99 Today — Unbelievable Savings!
It’s critical for your patients that you stay up-to-date on proper prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases.
Here's what you'll cover in this state-of-the-art online training course:
- Drug classes
- Pharmacokinetic Properties
- Concentration-dependent killing
- Time-dependent killing
- Post-antibiotic effect
- Common interactions with other drugs
- Define true allergy
- Sulfonamide antibiotics vs non-antibiotics
- Penicillin — Cephalosporin cross-sensitivity
- Differentiation
- Normal flora
- Common pathogens
- Trends
- Mechanisms of resistance
- Contributing factors
Community versus Hospital Acquired
- Differentiating between CA- and HA-MRSA
- Current clinical practice guidelines
- Pharmacologic management
- Extended Spectrum Beta-Lactamase (ESBL)
- What are ESBLs
- Pharmacologic management
- Carbapenem-Resistant Enterobacteriaceae (CRE)
- What are CREs
- Pharmacologic management
- Bacterial Etiology, Signs and Symptoms and Diagnosis
- Cystitis and pyelonephritis
- Complicated and uncomplicated
- UTIs in pregnancy
- Treatment (IDSA Guideline Treatment Algorithm)
- Acute
- Recurrent and relapse
- Risk factors
- Pharmacology management
- Fecal Transplantation
- Probiotics literature review
- Bacterial etiology
- Diagnosis
- Typical vs. atypical
- Treatment (IDSA/ATS Guidelines) and monitoring
- Outpatient vs. inpatient
- Empiric treatment
- Bacterial etiology
- Treatment (IDSA/ATS Guidelines)
- Sinusitis and pharyngitis
- Etiology (Viral vs. Bacterial)
- Treatment
- Cellulitis
- Bacterial etiology
- Strep. vs. Staph. vs. MRSA
- Signs & symptoms
- Treatment (IDSA Guidelines)
- Clinical features
- Diagnosis
- Pharmacology management
- Types of Vaccines
- General recommendations
- Contraindications & precautions
- Catheter-Associated Urinary Tract Infections
- Surgical Site Infections
- Ventilator-Associated Pneumonias
- Non-ventilator Associated Infections (overlooked HAI)
- Central-Line Associated Bloodstream Infections
- Carbapenem-resistant enterobacteriaceae
- Clostridium difficile
- Methicillin-resistant staphylococcus aureus
- Vancomycin resistant enterococcus
- Acinetobacter baumannii
- Avian vs. swine vs. seasonal influenza
- H1N1 pandemic results
- When to treat? When not to treat?
- Treatment with anti-virals and antibiotics
- New vaccines for flu
- Zoster/shingles
- Pneumoccocal
- MMR, Tdap, etc.
- Ebola: What we learned
- Mosquito-borne ("Zika", Dengue, Chickungunya, West Nile)
- Tick-borne (Lyme and Babesia)
- Cryptosporidiosis
- Hepatitis B
- Vaccination protocol for healthcare personnel
- Staff follow-up after significant exposures
- Treatments for persons chronically infected
- Outbreaks in healthcare
- Hepatitis C
- Treatment "cures" in 12-24 weeks
- Outbreaks in healthcare-dialysis settings
- HIV/AIDS
- New one pill daily treatment
- Healthcare exposure and appropriate prophylaxis
- Today's best approaches to treatment
- Skin testing vs. blood test for exposure
- Follow-up guidelines for healthcare workers conversion testing
Clinical expert Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN, knows that choosing an antibacterial agent can be challenging given the emerging trends in bacterial resistance.
In this incredible free training, Dr. Langlois discusses pharmacokinetic properties and new treatment guidelines for fungal infections, UTIs, pelvic inflammatory disease, cellulitis, diabetic foot infections, and multiple drug-resistant organisms. This video includes one additional pharmacology contact hour!
Now with Critical Corona Virus Updates
Valued at $499.97 — Yours today for only $149.99!
Click here for CE credit details
Jason Cota, PharmaD, MS, is an associate professor and the vice-chair of the Pharmacy Practice Department at the University of the Incarnate Word Feik School of Pharmacy. He also has over 10 years of experience practicing as an infectious disease clinical pharmacist at the San Antonio Military Medical Center, where he is a credentialed provider with prescriptive authority.
Click here for information about Jason CotaWilliam “Barry” Inman, BA-BS, CIC, has 31 years of experience as an epidemiologist. He works for the Brevard County Health Department in Merritt Island, Florida and is a faculty member for Brevard Community College and the University of Central Florida teaching classes on infection control.
Click here for information about William Barry InmanDr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN, is a critical care clinical specialist in the Surgical, Medical, Neurologic, Burn, CCU and Trauma ICUs of Cook County Hospital, Chicago. Drawing on over 30 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners and physicians.
Click here for information about Dr. Paul LangloisNow with Critical Corona Virus Updates
A $499.97 Value — Just $149.99 for a LIMITED TIME!
Click here for CE credit details